ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,180, issued on Nov. 18, was assigned to Pfizer Inc. (New York).
"Combinations for treatment of NAFLD/NASH and related diseases" was invented by Neeta Balkrishan Amin (Cambridge, Mass.), Arthur James Bergman (Salem, Conn.), Roberto Arnaldo Calle (Marlborough, Mass.), William Paul Esler (Clinton, Conn.), Albert Myung Kim (Newton, Mass.), Jeffrey Allen Pfefferkorn (Acton, Mass.) and Patrick Robert Verhoest (Newton, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method for treating fatty liver disease and related diseases or disorders with a therapeutically effective amount of a composition comprising from about 25 mg to about 1200 mg of (S)-2-(...